Shots: SIGA to receive $12.4M as upfront with total value $19.5M to support clinical & regulatory activities of TPOXX (tecovirimat) in its evaluation as post-exposure prophylactic to treat smallpox symptomatic […]readmore
Tags : tecovirimat
Shots: The approval is based on 12 clinical trials results assessing TPOXX (tecovirimat) in 700 patients, demonstrating no adverse effects ’ TPOXX (tecovirimat) receives 17-0 votes from FDA’s Antimicrobial Drug […]readmore